Ownership history in Walleye Capital LLC Β· 21 quarters on record
This page tracks every 13F SEC filing in which Walleye Capital LLC reported a position in PROCEPT BIOROBOTICS CORP (PRCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Walleye Capital LLC underperformed the S&P 500 by β11.2% annually on this PRCT position. Timing score: 37% (7/19 decisions correct). Average cost basis: $58.76. Maximum drawdown during holding period: β60.9%.
β Significantly underperformed the S&P 500 by 11.2% ann.
19 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
7 of 19 add/trim decisions correct
Best entry: $31.46 (2025 Q4) Β· Worst: $80.52 (2024 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
13 adds Β· 8 trims. Bought during 3 of 4 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size